Shah D M, Paty P S, Leather R P, Chang B B, Darling R C, Feustel P J
Albany Medical Center Hospital, Section of Vascular Surgery, New York.
Surg Gynecol Obstet. 1993 Sep;177(3):283-7.
To evaluate factors for the optimal outcome after tibial arterial bypass for lower extremity ischemia, we analyzed our experience with 1,359 such bypasses during the last ten years. There were 869 males and 490 females, of whom 739 patients (54 percent) had diabetes. The average age was 68 years. One thousand and twenty-four bypasses were performed using the atraumatic valve incision in situ technique, 281 bypasses using free vein grafts and 54 bypasses with synthetic materials. These bypasses were taken to the anterior tibial (312 patients), posterior tibial (341 patients), peroneal (520 patients) and dorsalis pedis arteries (125 patients). Inflow arteries included external iliac (two patients), common (435 patients), superficial (472 patients) and profunda femoris arteries (259 patients). In certain instances, popliteal and tibial arteries were used for inflow (short bypasses). Limb salvage was the significant indication (95 percent). The overall cumulative primary patency rate at five years was 68 percent and secondary patency was 76 percent. In situ bypasses had the best secondary patency rate of 80 percent at five years followed by free vein grafts of 70 percent and synthetic bypasses of 33 percent. The choice of inflow or outflow arteries did not influence the patency rate in any category. The overall limb salvage rate was 94 percent at five years. Short bypasses using free vein grafts had a similar patency to long free vein graft but lower patency than long in situ bypasses. These data demonstrate that bypasses to tibial arteries, using autogenous vein for ischemia of the lower extremity and limb salvage, have long term durability. In situ bypass with a complete saphenous vein is the best conduit for such reconstructions. We suggest that tibial arterial bypass should be strongly considered in all instances for limb salvage when autogenous vein is available before resorting to primary amputation.
为评估下肢缺血行胫动脉搭桥术后实现最佳疗效的相关因素,我们分析了过去十年间1359例此类搭桥手术的经验。其中男性869例,女性490例,739例患者(54%)患有糖尿病。平均年龄为68岁。采用无创瓣膜原位切开技术进行了1024例搭桥手术,281例采用游离静脉移植物搭桥,54例采用合成材料搭桥。这些搭桥手术的目标血管包括胫前动脉(312例患者)、胫后动脉(341例患者)、腓动脉(520例患者)和足背动脉(125例患者)。流入动脉包括髂外动脉(2例患者)、股总动脉(435例患者)、股浅动脉(472例患者)和股深动脉(259例患者)。在某些情况下,腘动脉和胫动脉被用作流入血管(短搭桥)。肢体挽救是主要指征(95%)。五年时总的累积原发性通畅率为68%,继发性通畅率为76%。原位搭桥五年时继发性通畅率最佳,为80%,其次是游离静脉移植物,为70%,合成材料搭桥为33%。流入或流出动脉的选择对任何类别中的通畅率均无影响。五年时总的肢体挽救率为94%。采用游离静脉移植物的短搭桥与长游离静脉移植物的通畅情况相似,但低于长原位搭桥。这些数据表明,采用自体静脉对下肢缺血进行胫动脉搭桥及肢体挽救具有长期耐久性。使用完整大隐静脉的原位搭桥是此类重建的最佳管道。我们建议,在有自体静脉可用的所有情况下,为挽救肢体,在考虑进行一期截肢之前应强烈考虑行胫动脉搭桥。